Two or three issues side by side. Only issues that are open, upcoming or awaiting listing appear — those are the ones a comparison can act on, and the ones whose figures are actually published.
3 is the most that fits side by side. Remove one to add another.
| Comparing | AE Augmont Enterprises LimitedMainboard · Upcoming | TI Tempsens Instruments (India) LimitedMainboard · Upcoming | SP Symbiotec PharmalabMainboard · Upcoming |
|---|---|---|---|
| Issue | |||
| Board | Mainboard | Mainboard | Mainboard |
| Status | Upcoming | Upcoming | Upcoming |
| Price band | ₹750 – ₹788 | ₹285 – ₹300 | ₹988 |
| Lot size | 19 shares | 50 shares | |
A row is shown only where at least one of these issues has published the figure; a dash means that company has not. Nothing here is a recommendation — CAPITA1 is not registered with SEBI as an investment adviser or a research analyst.
| — |
| Minimum investmentOne lot at the upper band | ₹14,972 | ₹15,000 | — |
|---|
| Issue size | ₹825 Cr | ₹650 Cr | — |
|---|
| Face value | ₹5 | ₹4 | — |
|---|
| Registrar | MUFG Intime India Private Limited | KFin Technologies Limited | — |
|---|
| Timeline | |||
|---|---|---|---|
| Open date | 21 Aug 2026 | 20 Aug 2026 | 24 Aug 2026 |
| Close date | 25 Aug 2026 | 24 Aug 2026 | 27 Aug 2026 |
| Allotment date | 26 Aug 2026 | 25 Aug 2026 | 28 Aug 2026 |
| Listing date | 28 Aug 2026 | 27 Aug 2026 | 1 Sep 2026 |
| Valuation | |||
|---|---|---|---|
| P/E ratioAt the upper band. Null where earnings are negative. | 19.48x | 35.93x | 51.73x |
| EPS | ₹40.45 | ₹8.35 | ₹19.1 |
| NAV per share | ₹111 | ₹61.66 | ₹184.69 |
| Return on equity | 51.04% | 13.54% | 11.19% |
| Return on net worth | 49.52% | 13.55% | 9.48% |
| Return on capital employed | 40.27% | 21.61% | 11.56% |
| EBITDA margin | 0.41% | 24.83% | 26.59% |
| Debt to equity | 0.01 | 0.15 | — |
| Market | |||
|---|---|---|---|
| Grey market premiumUnofficial estimate — not an exchange price | ₹160 | — | — |
| Subscribed (overall) | 0.00x | 0.00x | — |